PBYI Q1 2019 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$99M+49.0% YoY

Gross Profit

$91M91.9% margin

Operating Income

-$10M-10.2% margin

Net Income

-$10M-10.2% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+39.4%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$331M

Total Liabilities

$288M

Stockholders' Equity

$44M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$67M	+49.0%
Gross Profit	$91M	$60M	+51.5%
Operating Income	-$10M	-$23M	+56.9%
Net Income	-$10M	-$24M	+58.5%

Revenue Segments

License

$54M54%

Product

$46M46%